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ABSTRACT 
(ENGLISH VERSION) 
 
The employment of somatic stem cells (SCs) as therapeutic elements is an important goal in 
the field of regenerative medicine. However, this is hampered by the fact that tissue stem 
cells are rare, difficult to purify and maintain in culture. Direct conversion of terminally 
differentiated cells back into their corresponding stem cells could provide a great effort in 
this sense. Here we show that ectopic YAP/TAZ expression in primary luminal differentiated 
cells of the mammary gland epithelium stably converts them into cells that display molecular 
and functional traits of mammary gland stem cells such as self-renewal, self-organization 
into structure that resemble the mammary gland in vitro and mammary gland reconstitution 
ability.  
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ABSTRACT 
(ITALIAN VERSION) 
 
L’utilizzo delle cellule staminali somatiche come agenti terapeutici è un importante obiettivo 
nell’ambito della medicina rigenerativa.  Tuttavia, questo è ostacolato dal fatto che le cellule 
staminale sono rare, difficili da purificare e da mantenere in coltura. La conversione diretta di 
cellule differenziate nelle corrispondenti cellule staminali potrebbe rappresentare una 
soluzione a questo problema. In questo lavoro viene mostrato come l’espressione di 
YAP/TAZ in cellule differerenziate dell’epitelio della ghiandola mammaria conferisca a 
queste cellule proprietà staminali sia a livello molecolare che a livello funzionale , come la 
capacità di auto-rinnovamento, l’auto-organizzazione in strutture che ricapitolano la 
ghiandola mammaria in vitro e la capacità di rigenerare un’intera ghiandola mammaria. 
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EXTENDED ABSTRACT 
 
Unlimited availability of somatic stem cells is a critical aspect for regenerative medicine. 
Tissue somatic stem cells are rare and difficult to purify hampering the possibility to use 
them to better understand stem cell biology and to develop regenerative medicine 
applications. Direct conversion of differentiated cells back into their corresponding stem 
cells has been proposed as a solution to overcome this problem, as plasticity has been 
described among tissue populations. Yet, the molecular traits that generate and maintain the 
stem cell status are poorly understood. YAP and TAZ, the nuclear effectors of the Hippo 
signaling pathway, are potent inducers of tissue growth during development and they play 
also a key role in tissue regeneration after damage. Moreover, abnormal YAP/TAZ activity 
was associated to tissue overgrowth and acquisition of cancer stem cell traits. These 
evidences suggest a role of YAP/TAZ in the generation and maintenance of the stem cell 
state when natural or pathological conditions require the expansion of the stem cell 
compartment.  
Here we found that in the mammary gland YAP and TAZ are expressed in the mammary 
gland stem cells population and that they are the endogenous factors required to sustain the 
self-renewal ability of the mammary gland stem cells in vitro. These evidences prompted us 
to investigate if YAP/TAZ expression could confer stem cell traits to luminal differentiated 
cells (LDs) of the mammary gland. We found that expression of YAP/TAZ stably convert 
LDs in cell displaying molecular and functional characteristics of mammary gland stem cells 
such as self-renewal capacity and self-organization into tissue like structure that can be 
expanded as organoid cultures ex vivo. Mammary organoids resemble the mammary gland 
both at structural and functional level. The YAP-induced stem cell state can be transmitted 
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through cell generations without need of continuos YAP/TAZ expression indicating that a 
transient expression of YAP/TAZ is sufficient to induce a stable stem cell state and that 
somatic stem cells can be reprogrammed while preserving their lineage conversion. 
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INTRODUCTION 
 
Somatic stem cells (SCs) are undifferentiated cells able to self-renew and to generate a 
differentiated progeny. They are involved in fundamental homeostatic processes such as 
tissue renewal and tissue regeneration after injury, making them a point of attraction for 
applications in regenerative medicine. However, the study of the mechanism governing the 
stem cell status is hampered by the fact that SCs are rare and difficult to purify and expand ex 
vivo. Recently, the development of three-dimensional culture systems allowing stem cells to 
self-organize into structure called “organoids” represents a revolutionary improvement in this 
direction. Unfortunately, the generation of organoids requires the isolation of stem cells as 
starting material. 
An attractive alternative to this problem is represented by the direct conversion of 
differentiated cells back into their corresponding tissue-specific stem cells. Recently, several 
reports highlighted how somatic cells display an high grade of plasticity, as differentiated 
cells can return to a stem cell status under particular conditions such as tissue damage 
(Blanpain and Fuchs, 2014) suggesting that differentiated and stem cell state are 
interchangeable in response to extrinsic cellular cues. 
However, how this plasticity is regulated and the factors involved in the generation and 
maintenance of the stem cell status are poorly understood.  
It has been demonstrated the two transcription co-factors YAP and TAZ are required for the 
expansion of somatic stem cells during tissue regeneration after damage and for sustaining the 
aberrant cell growth during the initial phases of oncogenic transformation, suggesting a role 
of YAP/TAZ as stemness factor (Ramos and Camargo, 2012). 
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Thus YAP/TAZ could be key regulators of the maintenance or acquisition of stem cell traits 
whenever generation or expansion of stem cells is required to face natural or pathological 
conditions. 
  
YAP/TAZ and their regulators 
 
Hippo Signaling Pathway 
YAP (Yes-associated protein) and TAZ (Transcriptional co-activator with PDZ-binding 
domain; also known as WWTR1) are two homologous transcription co-factors that were first 
discovered as the downstream effectors of the Hippo signalling pathway. The Hippo 
signalling is at the centre of mechanism that controls tissue growth and the organ size (Pan, 
2010).  
 The components of the intracellular signalling cascade of the Hippo pathway were first 
discovered in Drosophila; the core cassette is composed by the protein kinase Hippo and its 
partner Salvador, the protein kinase Warts and its adaptor protein Mob as tumour suppressor 
(Mats). The investigation of the Hippo pathway revealed that there are several aspects of the 
pathway that are conserved from flies to mammals. At the core of the mammalian pathway 
are the two sterile serine/threonine kinase MST1 and MST2 (the orthologs of Hippo in 
Drosophila): when activated, MST1/2 bind their adaptor protein Salvador1 (SAV1/WW45) 
leading to the formation of an active enzymatic complex that phosporylate the large tumour 
suppressor 1 and 2 kinases (LATS1/2), as well as MOB1, allowing the formation of an active 
LATS1/2-MOB1 complex. The activation of LATS1/2-MOB1 complex lead to the 
phosphorylation of YAP and TAZ: phosphorylation of YAP at Ser127 and TAZ at Ser89 
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generate a binding consensus for 14-3-3 proteins leading to the cytoplasmatic retention of 
YAP and TAZ. 
Moreover, LATS1/2-mediated phosporilation also inhibits YAP/TAZ by promoting their 
degradation through ubiquitination. The phosphorilation of S381 (S311 in TAZ) primes YAP 
for additional phosporylation by CK1 kinase resulting in the generation of a “phosphodegron” 
recognized by β-TRCP leading to YAP/TAZ polyubuquitination and degradation. (Liu et al., 
2010; Zhao et al., 2010). Despite the presence of the phosphodegron, YAP is a relatively 
stable protein while TAZ is very protein degradation is the main process controlling TAZ 
inhibition. Deregulations of the Hippo pathway lead to the accumulation of YAP/TAZ in the 
nucleus.  
YAP and TAZ are transcriptional co-activators lacking DNA binding domain and thus require 
the association with a DNA-binding partner to activate their transcriptional program. Several 
reports identified the TEAD family of transcription factors (Scalloped in Drosophila) as the 
most important mediator of YAP and TAZ activity (Zanconato et al, 2015; Zhang et al, 2009; 
Zhao et al, 2008) (Figure 1A). Moreover YAP and TAZ are involved in the regulation the 
transcriptional activity of others transcription factors such as SMADs, p73, RUNX, and 
PPAR-γ (reviewed in  Piccolo et al., 2014). 
As mentioned above Hippo pathway is involved in the control of the organ size indeed 
mutations of components of the Hippo pathway or overexpression of YAP/TAZ result in 
organ overgrowth due to the increase in cell division and a decreased susceptibility to cell 
death (Piccolo et al., 2014; Zhao et al., 2010). In Drosophila, overexpression of Yorkie 
(YAP/TAZ orthologue) leads to a massive growth of the eyes and enlargement of the wing 
imaginal discs (Figures 1B-C) (Dong et al., 2007; Huang et al., 2005). Since the components 
of the pathway are conserved from flies to mammals, similar phenotypes were observed in 
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transgenic mice. For instance, overexpression of YAP in the liver results in a massive liver 
overgrowth (Figure 1D) (Dong et al., 2007), while conditional knockout of the MST adaptor 
protein Salvador leads to cardiomegaly (Figure 1E) (Heallen et al., 2011). 
 
Regulation of the Hippo pathway by cell architecture and cell polarity 
The core components of the Hippo pathway and the mechanism leading to YAP/TAZ 
phosphorilation and inactivation are well known but the mechanisms regulating the Hippo 
pathway are not well understood. 
Several reports pointed out a role of cell-cell adhesion and cell polarity (reviewed in Piccolo et 
al., 2014). Merlin, encoded by NF2 tumour suppressor locus, has been described to be 
involved in this type of regulation. In confluent monolayer of epithelial cells, Merlin/NF2 is 
localized at the cell membrane in proximity to cell-cell junctions were it may promote the 
correct assembly of protein scaffolds that allow the activation of LATS (Yin et al., 2013). 
Merlin reconstitution in NF2 deficient MDA-MB-231 cell line (breast cancer cells) results in 
a strong reduction of the YAP/TAZ activity that is totally LATS-dependent (Aragona et al., 
2013).  
The correct cell architecture and cell polarity have been shown to be relevant regulator of 
YAP/TAZ activity and this has been linked to the localization of cell polarity determinants, in 
particular Scribble. At the cell membrane Scribble serves as adaptor for the Hippo kinases 
promoting the assembly of a MST-LATS-TAZ complex required for LATS activation and 
TAZ inhibition. The loss of cell polarity and architecture (for instance during the initial 
phases of the epithelial to mesenchymal transition) leads to Scribble delocalization and 
activation of TAZ (Cordenonsi et al., 2011). 
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Recently it has been showed that other polarity determinants are involved in the regulation 
YAP/TAZ activity. Angiomotin (AMOT) family proteins were shown to interact with 
YAP/TAZ recruiting them to cell-junctions and inactivating through phosphorilation 
dependent and independent mechanisms (Chan et al., 2011; Hirate et al., 2014). Moreover it 
has been showed that α-catenin (the linker between cadherins and the actin cytoskeleton) is 
an inhibitor of YAP activity in keratinocytes since perturbations in the E-cadherin/α-catenin 
complex lead to a decrease in YAP phosporilation and promotion of YAP nuclear localization 
(Kim et al., 2011). 
The large variety of connection between Hippo pathway and the cell polarity suggest that the 
cell architecture and adhesive properties take an important role in the regulation of YAP/TAZ 
activity. 
 
Role of the Hippo pathway in the early embryonic development 
YAP and TAZ have a key role during embryo development as demonstrated by the severe 
phenotypes associated to YAP/TAZ deletion at the embryo stages. Double knockout mutants 
die before implantation (Nishioka et al., 2009). YAP null mice die early after gastrulation (E 
8.5) and they are characterized by defects in the elongation of the body axis combined with 
abnormal neural morphogenesis and defects of the extraembryionic tissues. As for YAP 
knockout, deletion of TAZ is lethal but a fraction of these mice develop to term and die for 
renal and pulmonary diseases (Makita et al., 2008). 
YAP and TAZ play also an important role in cell fate decisions: it has been shown that, at the 
morula stage, YAP/TAZ are localized in the cytoplasm of inner mass cells while they are 
enriched in the nucleus of trophoectodermal cells where they promote the expression of Cdx2 
and thus the specification of the trophoectodermal lineage (Nishioka et al., 2008). 
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Regulation of YAP/TAZ by mechanical cues 
Hippo-mediated phosphorilation of YAP and TAZ is one the most important mechanisms 
involved in the regulation of the activity of these two co-transcription factors but it is not the 
only one. Recent findings highlighted how mechanical signals such as cell-shape, extra-
cellular matrix stiffness and cytoskelatal tension are involved in the regulation of YAP and 
TAZ activity (Dupont et al., 2011; reviewed in Halder et al.,2012). 
In cells cultured on stiff extra-cellular matrix (ECM), YAP and TAZ are localized into the 
nucleus where they can induce the transcription of their target genes; conversely, if cells are 
cultured on soft ECM, YAP and TAZ are re-localized into the cytoplasm and thus inactivated 
(Dupont et al., 2011). YAP/TAZ can also respond to changes in cytoskeletal tension: if cells 
are allowed to spread over the ECM, the cytoskeletal adaptation to the stretch conditions 
leads to YAP/TAZ nuclear accumulation and activation inducing proliferation and inhibiting 
differentiation; at the opposite, in cells grown on small adhesive ECM and forced to adopt a 
round and compact shape, YAP and TAZ are localized in the cytoplasm and cells stop to 
proliferate and start differentiation. YAP/TAZ appear to be not only sensors of mechanical 
cues but also crucial mediators of the biological effects of cell shape and ECM stiffness; for 
instance endothelial cells died when they are forced to be small but increasing YAP/TAZ 
levels in small cells allow them to proliferate; on the contrary, downregulation of YAP/TAZ 
in spread cells causes them to die (Dupont et al., 2011). Moreover, ECM stiffness is involved 
in the differentiation of mesenchymal stem cells (MSC) into different cell types (Engler et al., 
2006). High stiffness (elevated YAP/TAZ) prompt cells to differentiate into osteocytes while 
a softer ECM (low YAP/TAZ) render cells competent toward adipocyte differentiation 
(Dupont et al., 2011). YAP/TAZ activity could be regulated also by cell density and tissue 
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architecture. YAP and TAZ inactivation underlies the contact inhibition of proliferation (CIP) 
(Zhao et al., 2007) that is defined as the arrest of cell division when cells occupy all the space 
available for their growth. A “two step” model recently explained the role of YAP/TAZ in 
this phenomenon (Aragona et al., 2013): when cells start to get in contact with each other, 
YAP/TAZ get phosphorilate by LATS and thus inactivated; this contributes for only 30% of 
growth inhibition. Successively, as cells continue to proliferate and become crowded, the 
reduction of the growth area result in an impairment of YAP/TAZ mechanical pathway in a 
manner not dissimilar from YAP/TAZ inhibition in cells cultured in small adhesive areas. 
 
Crosstalk between YAP and Wnt signaling 
YAP and TAZ are not only sensor of the physical environment and tissue architecture but they 
can also mediate the response to chemical soluble growth factors, indeed it has been recently 
demonstrated an integration between YAP/TAZ and the Wnt pathway (Azzolin et al., 2014). 
The core of the Wnt pathway is the regulation of the intracellular transducer β-catenin: in the 
absence of Wnt, β-catenin is constantly degraded by a cytoplasmic destruction complex 
consisting of a central scaffold protein Axin, that interacts with other proteins such as 
adenomatous polyposis coli gene product (APC), casein kinase 1 (CK1) and glycogen 
synthase kinase 3 (GSK3). In absence of Wnt, the amino-terminal region of β-catenin is 
sequentially phosphorilated by CK1 and GSK3 resulting β-catenin recognition by β−TrCP 
and β-catenin ubiquitination and degradation (He et al., 2004). The arrival of Wnt causes 
functional inactivation of the destruction complex leading to β-catenin accumulation in the 
nucleus and the formation of nuclear complexes with its DNA-binding partner TCF/Lef 
(Clevers, 2006). Recently it has been discovered that YAP/TAZ are components of β-catenin 
destruction complex: they are sequestered in the cytoplasm in the destruction complex and 
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more, YAP/TAZ association to Axin is required for recruitment of β−TrCP to the complex. 
Indeed, in “Wnt OFF” conditions, depletion of YAP/TAZ leads to the activation of β-catenin 
transcriptional program. On the other hand, in “Wnt ON” conditions, the binding between 
Axin and the Wnt receptor LRP6 leads to the release of YAP/TAZ from the destruction 
complex. In this situation the destruction complex is “invisible” to β−TrCP, favoring β-
catenin accumulation in the nucleus and the activation of Wnt-induced, YAP/TAZ dependent 
transcriptional program (Azzolin et al, 2014). 
 
YAP/TAZ AND STEM CELLS 
 
Stem cells (SC) display the capacity to self-renew when they divide and to generate a 
differentiated progeny. This cycling activity is fundamental in maintaining tissue homeostasis 
and to respond to physiological and environmental stimuli. As mentioned above, Hippo 
pathway is involved in the control of the organ size and mutation in components of the 
pathway lead to phenotypes characterized by tissue and organ overgrowth suggesting a role of 
YAP and TAZ in the regulation of SC and progenitor self-renewal (Ramos and Camargo, 
2012; Zhao et al., 2010). 
The use of conditional mutants for the Hippo pathway components and inducible transgenic 
mouse models highlighted a role of YAP/TAZ in the expansion of progenitor cell 
compartment and in cell fate decision in diverse tissues and organs. The simple 
overexpression of YAP in the liver of transgenic mice leads to the acquisition of biliary/duct 
liver progenitor traits by the hepatocyte (Yimlamai et al., 2014). Gain of YAP in the basal 
layer of the epidermis results in the expansion of the stem cell compartment with increased 
keratinocytes proliferation, defective stratification and reduced terminal differentiation; vice 
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versa deletion of YAP from the basal layer in embryos epidermis leads to reduced stem cell’s 
self-renewal resulting in skin loss (Schlegelmilch et al., 2011; Zhang et al., 2011). In the adult 
intestine YAP expression is restricted to crypt compartment, that is enriched in stem cells, 
and overexpression of YAP induces the expansion of undifferentiated progenitors (Camargo 
et al., 2007). YAP/TAZ are also required for the regulation of stem cell expansion after 
injury, indeed inactivation of YAP severely impairs epithelial proliferation and crypt 
repopulation in the intestinal epithelium after DSS treatment (dextran sulfate sodium; an 
inductor of colitis) (Cai et al., 2010).  
 Some evidences highlighted a role of YAP/TAZ not only in normal stem cells but also in 
cancer stem cells (CSC). CSCs are the driving force for the growth of solid tumours, 
sustaining the proliferative potential, the resistance to chemotherapy and the loss of 
differentiation markers (Visvader, 2012).  Recent findings demonstrated that TAZ activity is 
required to empower CSC characteristics to non-stem cancer cells.  In particular, gain of TAZ 
endows tumor-initiating capacity to non stem-cancer cell populations and loss of TAZ impairs 
this capacity in CSC (Bartucci et al., 2014; Cordenonsi et al., 2011). Moreover, YAP/TAZ 
have been associated with the formation of metastasis of lung and breast cancer (Bartucci et 
al. 2014, Lamar et al., 2012; Lau et al., 2014) and also that loss of TAZ impairs tumorigenic 
potential and invasiveness in glioblastoma (Bhat et al., 2011). 
However, the idea that YAP/TAZ are stemness factors (Ramos and Camargo 2012) is based 
on distinct and poorly understood observations: the organ overgrowth in Hippo mutants 
embryos and the preferential localization of YAP/TAZ proteins in the stem cell niche of adult 
tissues; the role of YAP/TAZ during embryonic development is poorly understood and at the 
same time the connection between tissue-specific stem cells and their embryonic counterparts 
is not clear. Moreover conditional inactivation of YAP in adult mammary gland, pancreas, 
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liver and also double YAP/TAZ inactivation in the intestine showed that YAP/TAZ activity is 
dispensable for normal tissue homeostasis (Azzolin et al., 2014, Chen et al., 2014; Zhang et 
al., 2010, Zhang et al., 2014).  However YAP and TAZ are essential in conditions in which 
stem cells need to be expanded for tissue regeneration or after tumour initiation.  
 
ORGANOIDS 
The employment of stem cells for use in regenerative medicine and disease modelling in vitro, 
is hampered by the fact that somatic stem cells are rare, difficult to purify and to expand 
maintaining their multi-lineage differentiation potential in vitro. 
However, advances in understanding the key role of the stem cell niche and the signal 
involved in stem cell maintenance lead to the development of 3D culture systems that sustain 
the stem cell-driven formation of organoids (reviewed in Barker 2016). Organoids can be 
defined as a cluster of organ-specific cell types developed from stem cells that are able to 
self-organize in vitro into tissue like structure. They can be generated either from isolated 
stem/progenitor cells or from isolated fragment of the tissue from the corresponding organ 
(Koo et al., 2012). In recent years, organoid cultures have been developed from many tissues 
such as mammary gland (Dontu et a., 2003), small intestine (Sato et al., 2009), liver (Huch et 
al., 2015), pancreas (Huch et al., 2013), prostate (Gao et al., 2014), stomach (Bartfeld et al., 
2015). Organoids resemble the architecture of the organ from which they derive and also 
recapitulate the stem cell differentiation hierarchy allowing in vitro studying of the 
mechanism involved in the determination of stem cell fate. Moreover, under appropriated 
stimuli, they could resemble also specific functions of the tissue from which they derive.  
Organoids could be amenable to standard experimental manipulations used for cell lines, such 
as small interfering RNA and DNA transfections, infection with recombinant viruses and 
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storage by freezing (Koo et al., 2012). They can also be analysed by standard techniques, 
such as immunohistochemistry and confocal immunofluorescence, gene expression and mass 
spectrometry. Importantly, transgenic alleles could be manipulated in organoid culture to 
follow their effect during time. 
The possibility to grow organoids would open new perspectives in the study of stem cells and 
tissues in various contexts. For instance, adult stem cells can be propagated in organoids for 
long time (also years) without genomic alterations. Moreover, organoids could have an 
important role in modelling human disease in vitro and also in generating isogenic adult 
tissues for regenerative procedures and transplantation. 
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AIM OF THE STUDY 
 
 
As described in the introduction, tissue cell populations display a certain grade of plasticity 
leading to the dedifferentiation of differentiated cells back into their corresponding stem cells 
when natural or environmental conditions require the expansion of the stem cell 
compartment (Blanpain and Fuchs, 2014).   
Disregulation of the Hippo pathway has been recently associated to with cellular 
dedifferentiation indeed. For instance, in liver the inactivation of the Hippo signaling leads to 
a massive organ growth due in part to a transient lineage conversion of hapatocytes into 
biliary cells (Yimlamay et al., 2014). In the context of tumours, it has been shown that the 
activation of TAZ could confer cancer stem cells traits to non-stem cancer cells (Cordenonsi 
et al., 2011). 
These evidences suggest the possibility that expression of YAP and TAZ in differentiated 
cell, not only cancer cells but even normal differentiated cells, could confer them 
characteristics of stem cells.  
We tested this hypothesis in one of the most established system to study epithelia’s 
homeostasis: the mammary gland. We first characterized YAP/TAZ expression and role in 
the subpopulations that compose the mammary gland and then we tested if ectopic YAP/TAZ 
expression in differentiated cells of the mammary gland could empower them characteristics 
of stem cells.  
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RESULTS 
 
Isolation of mouse primary mammary epithelial cells (MECs) 
The mammary gland represents one the most important paradigm for the study of epithelia’s 
homeostasis and the mechanisms involved in tissue regeneration and maintenance. Previous 
works demonstrated that activation of YAP/TAZ in breast cancer cells could confer stem 
characteristics to non-stem cancer cells (Cordenonsi et al., 2011, Piccolo et al., 2014). Based 
on these data we thus hypothesized that expression of YAP/TAZ could confer stem 
characteristics also to normal differentiated mammary gland cells. 
To address a possible role of YAP/TAZ in these processes, we started with the isolation of the 
cell subpopulations that compose the mammary gland epithelium. For this purpose primary 
mammary epithelial cells were isolated from mammary gland of 8 to 12 weeks old C57BL/6J 
virgin mice. After mechanical dissection and enzymatic digestion of the glands, we purified 
by Fluorescence Activated Cell Sorting (FACS) lineage negative (Lin-) and EpCAM positive 
epithelial cells using CD49f and CD61 as surface markers (Guo et al., 2012). These 
procedure allowed distinguishing of three cell populations: a) Mammary gland stem cells 
enriched fraction (MaSC) (EpCAMlow, CD61+, CD49fhigh); b) Luminal Progenitors cells (LP) 
(EpCAMhigh, CD61+, CD49flow); c) Luminal Differentiated cells (LD) (EpCAMhigh, CD61-, 
CD49flow) (Figure 2A). These experiments were conducted in collaboration with Professor G. 
Basso and Dr. C. Frasson (Children’s hospital / Città della Speranza, Padova). 
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Characterization of the mammary gland subpopulations 
To validate and further characterize the FACS-purified cell populations we evaluated, by 
qRT-PCR, the expression of basal and luminal markers.  As expected, MaSCs were 
characterized by the highest expression of basal keratins such as K14, K5 and a lower 
expression of luminal keratins such as K8, K19 when compared to Luminal Differentiated 
cells and Luminal Progenitors cells. Moreover MaSCs display the highest expression of stem 
(e.g: p63, Lgr5, Procr) and myoepithelial markers (e.g: Myh11, α-Sma) (Figure 2B) 
(Chakrabarti et al., 2014; Wang et al., 2015) that is in line with the finding that the MaSCs 
enriched population is heterogeneous: it is composed by both basal and myoepithelial cells 
that have been showed to display stem characteristics. Western blot analysis confirmed the 
differential expression of basal and luminal keratins among the FACS-purified populations 
(Figure 2C). 
We next functionally characterized our population by measuring their colony forming 
capacity and self-renewal ability, which are cardinal properties of the stem cells. For this 
purpose, cells were seeded in colony forming medium containing 5% of Matrigel (see 
methods) in order to allow the formation of solid outgrowths from single cells.  As expected 
only MaSCs displayed the ability to form colonies that can be passeged through various 
generation; LPs do form cavitated spherical colonies but these cannot be passaged indicating 
that these cells are void of self-renewal ability; in contrast LDs remained as single cells 
(Figure 2D).  
Another cardinal property of mammary gland stem cells is the ability to regenerate an entire 
mammary gland with MaSCs contributing both to the luminal and myoepithelial lineages 
(Blanpain and Fuchs 2014). As shown in Figure 2E, injection of the FACS-purified MaSCs 
enriched population into the cleared fat pad of mice triggered regeneration of an entire ductal 
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tree; in line, LDs were completely void of the capacity to regenerate when injected into the 
cleared fat pad. 
Taken togheter, these findings indicate that our FACS profiling is efficient at identifying the 
three main populations that compose the mammary gland epithelium. 
 
Western blot analysis showed that YAP/TAZ proteins are expressed in MaSC enriched 
population and Luminal Progenitors cells while are barely detectable in Luminal 
Differentiated cells (Figure 2F). Moreover, measuring the expression of two established 
YAP/TAZ target genes (Ctgf and Axl) (Zanconato et al., 2015), by RT-qPCR, we found that 
MaSCs and LP cells display an higher transcriptional YAP/TAZ activity than LDs (Figure 
2G). 
Based on these data, we next argued if YAP/TAZ could have functional role in the MaSCs. 
For this purpose I teamed with Tito Panciera and employed mouse conditional knockout 
alleles of YAP/TAZ (Yapfl/fl; Tazfl/fl). MaSCs from these mice were FACS-purified as above 
and single cell suspension of MaSCs was infected with adenoviral vectors bearing the Cre 
recombinase (Adeno-Cre) or GFP as control (Adeno-GFP). Cells were then plated in colony 
medium to allow the formation of solid outgrowths from single cells. In these conditions only 
Yapfl/fl; Tazfl/fl MaSCs infected with Adeno-GFP formed solid outgrowths while genetic 
ablation of YAP/TAZ, by adeno-Cre delivery in Yapfl/fl; Tazfl/fl MaSCs, severely impaired the 
organoid forming ability (Figure 2H) These data indicate that YAP/TAZ not only are 
expressed and transcriptionally active only in mammary gland stem cells and not in luminal 
differentiated cells, but also that YAP/TAZ are endogenous factor required for the expansion 
of MaSCs in vitro. 
 
	   24	  
YAP/TAZ expression revert mammary gland differentiated cells into MaSC-like cells 
Given that YAP/TAZ are required for the expansion and self-renewal of mammary gland 
stem cells and also that the activation of YAP/TAZ in mammary tumors can convert non-
stem cancer cells into cancer stem cells (Cordenonsi et al., 2011), we hypothesized that 
expression of YAP/TAZ may confer stem characteristics also to normal mammary 
differentiated cells. 
To address this, FACS-purified Luminal Differentiated cells, obtained as described above, 
were plated on collagen-coated dishes and transduced with doxycycline-inducible lentiviral 
vectors bearing wild-type (YAPwt or TAZwt) or the activated version of YAP and TAZ 
(YAP5SA or TAZ5SA) lacking the inhibitory LATS phosphorilation sites. As control, cells 
were transduced with a lentiviral vector encoding for EGFP. Cells were cultured in 
doxycycline containing medium for 7 days after transduction and then plated at clonogenic 
density in colony forming medium to allow the formation of solid colonies from single cells 
(Figure 3A).  Interestingly, expression of YAP or TAZ in LDs allowed them to form solid 
colonies that were indistinguishable from those generated by MaSCs, while LDs transduced 
with EGFP control vector remained as single cells without ever originating a single colony in 
33 experiments (Figure 3B-C). Furthermore, transduction of LDs with an inducible lentiviral 
vector bearing a transcriptionally inactive form of YAP (YAPS94A; unable to interact with 
TEAD) had no effect on the colony forming ability (Figure 3B-C), suggesting that this 
process could be linked to YAP-regulated gene transcription. These data indicate that 
YAP/TAZ expression in LDs confer them colony forming ability, that is one of the 
characteristics of stem cells. 
We next wanted to evaluate if YAP/TAZ expression in LDs could confer also self-renewal 
potential, which can be assayed by the ability to serially passage mammary colonies in vitro. 
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For this purpose I supported a series of experiments carried out by Luca Azzolin, in which 
we dissociated colonies from natural MaSCs and YAP/TAZ induced MaSCs. Cells were re-
seeded then in mammary colony medium without doxycycline. Secondary colonies were 
counted 2 weeks after seeding, dissociated and re-seeded in the same conditions to allow the 
formation of tertiary colonies. Colonies from YAP/TAZ-transduced LD cells, similarly to 
those generated from MaSCs, could form additional generations of colonies after single cell 
dissociation without changing the colony forming efficiency (Figure 3D-E). Moreover the 
colony forming ability after passaging was comparable in presence and absence of 
doxycycline, that is irrespective of ectopic YAP/TAZ expression, suggesting that transient 
expression of YAP/TAZ is sufficient to confer self-renewal potential to mammary epithelial 
cells.  
To verify if the conversion from LDs to MaSC-like state could be recapitulated also at single 
cell level, we induced YAP expression in single LDs plated in 96 well-plates (visually 
verified). Individual transduced LDs cells formed solid colonies with high frequency (18,5% 
on average in three independent experiments) that could be further passaged as clonal 
organoids with high efficiency. As expected transduction with EGFP control vector or 
YAPS94A vector had no effect on the colony forming ability of the single LDs transduced 
cells (0% either with EGFP and YAPS94A) (Figure 3F). We thus designated these 
YAP/TAZ induced MaSC-like cells as yMaSCs. Of note, overexpression of YAP in the 
purified MaSC-enriched population does not increase the colony forming ability indicating 
that even if rare MaSCs were present in the LDs starting population, these could not be 
expanded by YAP expression strengthening the notion that yMaSCs originate from YAP 
induced reprogramming of LDs (Figure 3G). 
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Lineage tracing of yMaSCs 
To further validate the notion that YAP expression converts differentiated cells to a SC fate 
we carried out genetic lineage-tracing experiments using LD cells purified from K8-
CreERT2; R26-LSL-YFP mice. For this purpose we FACS-purified LDs from these mice 
and, after plating, we exposed cells to a tamoxifen pulse leading to the excision of the stop 
cassette and to the irreversibly YFP labeling exclusively in Luminal Differentiated cells (K8 
positive cells) (Van Keymeulen et al., 2011) (Figure 4A). Cells were then transduced with 
inducible YAP expressing lentiviral vector and plated in Matrigel containing medium in 
order to allow the formation of colonies; empty vector was used as control (see above). As 
shown in Figure 4B, colonies that were generated from the reprogramming of LDs were 
entirely YFP positive attesting their origin from the luminal lineage. To validate that the 
expression of the CreERT2 was restricted only to LDs (K8 positive), we purified MaSCs 
from K8-CreERT2; R26-LSL-YFP, treated them with tamoxifen and plated in 5% Matrigel 
containing medium. As shown in Figure 4B, colonies arising from these MaSCs were 
entirely YFP negative (n=154, 0% YFP +) indicating that the Cre recombinase is active only 
in LDs and not in MaSCs. 
We next performed a complementary experiment taking advantage of K14-CreERT2; R26-
LSL-YFP mice. In this experimental setup, administration of tamoxifen leads to the YFP 
labeling exclusively of the MaSC enriched population (K14 positive cells) (Van Keymeulen 
et al., 2014) (Figure 4A). As above, FACS purified LDs and MaSCs were exposed to 
tamoxifen pulse in order to label only K14 expressing cells. LDs were then transduced with 
YAP-encoding vector and plated in 5% Matrigel containing medium to allow the formation 
of colonies. yMaSC colonies generated from K14-CreERT2; R26-LSL-YFP mice were 
entirely YFP negative (n=122, 0% YFP+) while control colonies generated from endogenous 
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MaSCs of the same genotype were totally YFP positive (Figure 4B). Taken togheter all these 
data strengthen the idea that yMaSCs derive from YAP reprogramming of Luminal 
Differentiated cells and not from the expansion of rare contaminating endogenous MaSCs.  
 
Characterization of the early steps of YAP induced reprogramming 
To characterize the initial phase of reprogramming, we carried out immunofluorescence 
analyses on the earliest yMaSCs emerging as colonies from YAP-expressing LD cells. 
Interestingly, we found that a large fraction of these colonies consists of cells double positive 
for K14 and K8 (Figure 5A,C). Moreover colonies were virtually lacking of any staining for 
the myoepithelial marker α-SMA (Figure 5B,C) suggesting that the early yMaSCs do not 
represent a transdifferentiation of LDs into myoepithelial cells; rather, the early yMaSCs 
appeared to represent a progenitor-like state distinct from those prevalently found in the adult 
mammary gland and reminiscent of embryonic/fetal mammary progenitor cells, that are 
indeed double K14/K8-positive and α-SMA negative (Wansbury et al., 2011). 
To get more insight on the nature of early yMaSCs, I teamed with Tito Panciera and Prof. 
Michelangelo Cordenonsi and performed RNA-seq analyses comparing the gene expression 
profiles of early yMaSC colonies, control LDs and MaSC-enriched basal cell populations.  
As shown in Figure 5D, the LD-to-yMaSC transition triggers downregulation of a group of 
luminal genes highly expressed in terminally differentiated cells (e.g., Estrogen Receptor and 
Wap, blocks A-B) and upregulation of a host of basal markers originally not expressed in LD 
cells such as K14, K5, DNp63, LGR4 (block F). In contrast, other markers remain repressed 
in early yMaSCs, including myoepithelial markers such as Myh11, Calponin1, Mrtf-a, 
Myosin-light chain kinase and Cd10, as well as Procr (an adult MaSC marker) (Wang et al., 
2015) (blocks D-E). This further reinforces the conclusions that YAP does not induce 
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transdifferentiation of LD into myoepithelial cells. Interestingly, a specific group of genes is 
exclusively induced in early yMaSCs (block G), and a significant fraction of these (61%) 
corresponds to genes also expressed in the fetal mammary gland. In line, a significant 
fraction of the luminal genes (54%) whose expression is retained by early yMaSCs (block C) 
represents genes also expressed by the fetal mammary gland (Wansbury et al., 2011). These 
data were validated also by qRT-PCR (Figure 5E).  It is important to note that this represents 
a very transient state, as when yMaSCs were transferred in organoid medium they readily 
mature into cells displaying a profile matching adult MaSCs that will give rise to fully 
mature mammary organoids (see below). Also note that direct plating of MaSCs, LD control 
EGFP-infected, as well as YAP-infected cells, directly into organoid culture conditions did 
not result in any outgrowth, indicating that the intermediate step in colony culture conditions 
is required for organoid development. 
 
To further validate the notion that YAP/TAZ truly convert LDs to a stem cell fate we take 
advantage of the LGR5-GFP mice (Barker et al., 2012), indeed it has been demonstrated that 
Wnt signaling is instrumental for the maintenance of somatic stem cells and that several 
tissue, including the mammary gland contain a Wnt responsive population marked by LGR5 
that is enriched in stem cells (Zeng et al., 2010; Clevers et al., 2014). We FACS-purified LDs 
from these mice and induced to express YAP by doxycycline administration (Figure 5F). 
LDs from LGR5-GFP mice were initially negative for GFP expression but readily turn it on 
(frequency >20%) upon induction of YAP indicating the activation of the LGR5 promoter 
and so a switch from a differentiated to a stem cell fate (Figure 5G-H). As control cells 
transduced with empty vector or YAPS94A (transcriptionally inactive version of YAP) were 
totally negative for GFP (Figure 5G-H).  
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The expansion, differentiation and regenerative potential of yMaSCs  
To verify if yMaSCs truly represents mammary gland stem cells we tested their ability to self-
organize in vitro into mammary tissue-like structures and to differentiate along distinct 
lineages. Since colonies were not suitable to appreciate and investigate about MaSCs and 
yMaSCs differentiation potential, we tried to establish a long-term culture system that allows 
yMaSCs to form mammary-gland like structures in vitro, taking advantage of the 
“organoids” culture system (Sato et al., 2009). For this purpose MaSC and yMaSC-derived 
colonies were transferred and embedded into 100% Matrigel, and overlaid with “organoid” 
medium. To optimize the culture conditions we tested the organoid forming capacity and 
self-renewal ability of colonies culturing them in different organoid media. We started testing 
the colony forming medium, in order to preserve the colony identity, but under these culture 
conditions cells rapidly died without possibility of expansion. Since it was demonstrated that 
MaSCs are dependent on Wnt protein for their expansion (Zeng e Nusse, 2010) we tried to 
improve our culture conditions by adding Wnt3a to the organoid medium. In these culture 
conditions cells maintained their shape and vitality but they were not able to regrow after 
single cell dissociation.  
We next tried to improve the culture conditions by adding EGF, Noggin and R-Spondin (see 
methods), three factors that were described for the culture of intestinal organoids (Sato et al., 
2009) and then maintained for the culture of other organoids type such as prostatic and liver 
organoids. Under these culture conditions, colonies started to form budding organoids in 2 
weeks: 64-75% (depending on the experiment) of yMaSC colonies evolved as organoids that 
were maintained and passaged without doxycycline. yMaSCs  derived organoids were 
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indistinguishable in growth pattern and size to those generated by endogenous MaSCs 
(Figure 6A-B). 
Histological analysis showed that yMaSCs derived organoids, similar to those generated from 
endogenous MaSCs, resemble the mammary gland architecture. They were composed by an 
E-Cadherin positive stratified epithelium (Figure 6C) in which internal cells surrounding a 
central cavity expressed marker of Luminal Differentiated cells such as K8 and K19 (Figures 
6D-E, G-H) while the outer cells expressed markers of basal/stem cells and myoepithelial 
cells such as K14, p63 and α-SMA (Figures 6D-I). Moreover, histological examination of 
lineage traced yMaSCs organoids (generated as above from K8-CreERT2; R26-LSL-YFP 
mice) showed that they are composed by YFP positive and K14 positive cells, confirming 
that they were originated by YAP induced reprogramming of LDs (Figure 6L). 
We next moved to characterize yMaSCs at the molecular level. For this, we FACS-purified 
yMaSCs from organoids and evaluated, by qRT-PCR, the expression of basal and luminal 
markers, using freshly purified endogenous adult MaSCs and LDs as controls.  Gene 
expression analysis revealed that organoid stage yMaSCs expressed basal markers (including 
myoepithelial markers such as α-Sma and Myh11) all to levels comparable to endogenous 
MaSCs while they are void of expression of luminal markers such as K8, K18 and Pgr. 
Organoid stage yMaSCs also express genes previously associated to adult MaSCs such as 
Lgr5, ΔN63 and Procr (Figure 7A). 
Moreover, unsupervised hierarchical clustering of gene expression profiles showed that 
organoids from MaSCs and yMaSCs could not be distinguishable (Figure 7B) indicating that 
MaSCs and yMaSCs are similarly potent.  
Mammary gland cells display the ability to produce milk when stimulated by hormones. To 
test if yMaSC organoids resemble the mammary gland also from at functional level, we 
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stimulated them by adding to the culture medium the hormone prolactin in presence of 
insuline and dexamethasone (Wartman et al., 1996) and then we evaluated by qRT-PCR the 
expression of genes known to be associated with the production of milk. Organoids derived 
from endogenous MaSCs were used as control. As shown in Figures 7C-D, the addiction of 
lactogenic stimulus triggered the expression of α e β-casein, characteristics of milk-
producing cells indicating that yMaSCs in vitro are able to differentiate in alveolar cells 
when exposed to the appropriate stimuli.  
Taken togheter all these data indicate that yMaSCs, similar to endogenous MaSC, display 
self-renewal potential and could generate epithelial like organoids that resemble the 
mammary gland at structural, functional and molecular level. 
 
YAP/TAZ are not only instrumental for the reprogramming of LDs but are also endogenous 
factors required to preserve the self-renewal potential of yMaSCS derived organoids in vitro. 
As for endogenous MaSCs, genetic ablation of YAP/TAZ by Adeno-Cre delivery in yMaSCs 
organoids derived from conditional knockout mice (Yap fl/fl; Tazfl/fl) bleached their capacity of 
regrow upon passaging (Figure 7E). Interestingly, induction of exogenous YAP in LDs 
turned on the expression of endogenous YAP/TAZ that remained expressed in yMaSCs 
derived organoids after ectopic YAP expression had been turned off (Figure 7F) suggesting 
that a transient YAP expression is sufficient to endow a loop of YAP/TAZ expression in 
yMaSCs derived organoids.  
 
Since the ability to trigger tissue regeneration is one of the characteristics of the mammary 
stem we wanted to test if yMaSCs display regeneration capacity after injection in cleared fat 
pad of mice. For this purpose, we transduced FACS-purified LD with vectors encoding for 
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inducible YAPwt and constitutive EGFP in order to trace injected cells. Cells were kept in 
doxycycline for 7 days and transplanted into the cleared mammary fat pad of NOD-SCID 
mice. Mice were then kept in doxycycline-free diet (Figure 8A.) Luca Azzolin conducted 
injection experiments in collaboration with Prof. Antonio Rosato (Istituto Oncologico Veneto 
IOV-IRCCS). Strikingly, cells acquired the ability to regenerate an entire mammary gland 
after a transient YAP expression (25%, n=16) (Figure 8B.) Regeneration of an entire 
mammary gland was observed when as few as 100 yMaSCs were injected in the cleared fat 
pad (33%, n=6). As control, LD cells transduced only with EGFP did not display any 
reconstituting activity (0%, n=28) (Figure 8C). By histological examination, reconstituted 
ductal threes obtained from yMaSCs were indistinguishable from those generated by 
endogenous MaSCs (Figure 8C); they were composed by an EGFP-positive stratified 
epithelium (Figure 8D) consist of a basal layer (expressing marker of basal cells such as K14 
and α-SMA) overlaid by cells expressing luminal marker such as K8 and K19 (Figure 8E-F). 
Interestingly, reconstituted mammary glands generated a dense ductal system ending in 
clusters of milk-secreting alveoli when these mice were impregnated (Figure 8G) indicating 
that, similar to endogenous MaSCs, yMaSCs retain multilineage differentiation potential in 
vivo.  
This collective set of experiments reinforces the notion that transient expression of YAP/TAZ 
in differentiated cells of the mammary gland is able to convert them into bona fide MaSCs.  
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DISCUSSION 
 
Dysregulation of the Hippo pathway has been associated to changes in cell fate decision in 
transgenic liver e mammary cells (Cordenonsi et al., 2011; Skibinski et al., 2014; Yimlamai 
et al., 2014). However the possibility to de novo generate tissue somatic stem cells through 
YAP/TAZ is fascinating, yet totally unexplored. Here we report that the expression of 
YAP/TAZ in luminal differentiated cells of the mammary gland epithelium generates cells 
with molecular and functional characteristics of their corresponding endogenous stem-cells, 
that can be expanded as self-propagating organoids ex-vivo. The stem cell state triggered by 
YAP/TAZ can be transmitted through several cell generations without continuous expression 
of exogenous YAP indicating that a transient YAP/TAZ expression is sufficient to stably 
endow an heritable stem cell state. 
 
YAP turns differentiated cells of the mammary gland into MaSC-like cells 
 
In this work we used several approaches to validate the notion that yMaSC derive from YAP-
induced reprogramming of luminal differentiated cells rather than from the amplification of 
pre-existing stem cells present in the starting population. 
A first indication in this sense derives from the characterization of the FACS-purified 
population. We used a well-established FACS protocol (Guo et al., 2012) and we validated by 
molecular and functional analysis that it is efficient in identifying the populations that 
compose the mammary gland epithelium. The experiments invariably provided very clear 
results: in no case we could detect emergence of colonies in control cultures transduced with 
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EGFP encoding vector or mutant YAP (YAPS94A) unable to interact with TEAD, indicating 
that our starting population is completely void of detectable SCs. 
A second indication derives from genetic lineage tracing experiments, in which we used 
established and well characterized Cre driver (K8-CreERT2) (Van Keymulen et al., 2011) to 
label and trace the fate of luminal differentiated cells. Colonies and organoids generated by 
YAP-induced reprogramming of LDs derived from K8-CreERT2; R26-LSL-YFP were 
entirely YFP positive attesting their origin from differentiated cells. Vice versa, colonies and 
organoids generated from endogenous MaSCs of the same genotype were invariable void of 
YFP expression strengthening the notion that Cre driver label exclusively differentiated cells 
and their progeny. Moreover the possibility that YAP could expand rare stem/progenitors 
present in the starting populations is inconsistent with the observation that YAP has no effect 
of the colony-forming capacity of endogenous MaSCs. Finally, the early yMaSCs 
immediately emerging after YAP expression are very different from normal, adult MaSCs as 
they resemble fetal mammary stem cells, that do not exist (or would be exceedingly rare) in 
the adult mammary tissue; the early yMaSCs could only be generated de novo. Collectively 
these data support the notion that yMaSCs emerge from the YAP-induced reprogramming of 
luminal-differentiated cells and not from the amplification of contaminant stem cells. 
YAP-induced reprogramming generates cells displaying traits of normal SC: yMaSCs can be 
expanded through multiple generations as self-expanding organoids ex vivo; yMaSCs-derived 
organoids resemble the architecture and the function of the mammary gland indicating that 
yMaSCs retain multilineage differentiation ability both in vitro and also in vivo, as injection 
of yMaSCs in the cleared fat pad leads to the reconstitution of an entire ductal tree. Moreover 
yMaSCs display remarkable overlaps with endogenous MaSCs also at the transcriptomic 
level. 
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Of note, differently from induced pluripotent stem cells (iPSCs), YAP induced stem cells 
maintain the epigenetic memory of the tissue of origin and are never tumorigenic as we never 
detected the emergence of tumors after yMaSC injection in the cleared fat pad of mice. 
 
YAP/TAZ and cellular plasticity 
 
Reversion from differentiated to a stem cells state rarely occurs in normal tissues but it occurs 
in situation such as tissue repair and oncogenic transformation (Blanpain and Fuchs, 2014; 
Mani et al., 2008; Skibinski et al., 2014;  Tetteh et al., 2014; Yimlamai et al., 2014). As 
described in the introduction, genetic depletion of YAP/TAZ in several adult epithelia has no 
effect on the normal tissue homeostasis but is fundamental for tissue regeneration, tumor 
growth (Azzolin et al., 2014; Cai et al. 2010; Zhang et al, 2014) and, as shown in this work, 
for the in vitro expansion of MaSCs. These evidences open a scenario in which YAP/TAZ 
could be proposed as regulators of cell plasticity and stem cell maintenance, whenever the 
expansion of endogenous stem cells or de novo generation from differentiated cells is 
required to face physiological or pathological conditions.  
Further work is required to understand the means by which YAP overcomes the differentiated 
state and triggers the generation of a SC state de novo. At the molecular level this is clearly 
linked to the YAP/TAZ transcriptional program, indeed yMaSCs generation is impaired using 
YAPS94A (unable to bind TEAD transcription factor) for the reprogramming. Gene-
expression studies provided some intriguing mechanistic insights, as we found that YAP 
induces several genes known to be instrumental for SC self-renewal and/or functionally 
implicated in MaSC biology, such as ΔNp63 (Chakrabarti et al., 2014). 
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YAP and TAZ are not only instrumental for the reprogramming of luminal differentiated cells 
but are also the endogenous factors required to maintain the self-renewal ability of MaSCs 
ex-vivo. In line, exogenous YAP can indeed install a self-sustaining loop in differentiated 
cells leading to a stable re-expression of endogenous YAP/TAZ in ySCs, where they are in 
turn required to preserve organoid-forming potential. It is thus tempting to propose the 
existence YAP/TAZ dependent stemness network whose components are still unknown. 
We can speculate that, during the reprogramming, YAP/TAZ could act at the level of 
composite enhancer elements of specific transcription factors to promote the expression of 
stem-specific genes and repressing the expression of terminally differentiated genes.  
 
YAP/TAZ as a novel paradigm for reprogramming 
 
Immortalized and transformed cell lines are the most important models to study the biology of 
normal cells and also to investigate pathological aspects of complex disease such as cancer, 
but their usefulness is still debated. The number of available cell lines is restricted and they 
are not useful to evaluate some important aspects of cell and tissue biology such as the cell 
structural organization inside the tissue, the dynamics of tissue growth and also specific 
functional aspects. Importantly, each cell line is different from genetic and epigenetic point of 
view as they derived from different patients carrying different genetic alterations. A potential 
application of the reprogramming procedure presented here is the possibility to generate 
patient-specific cells starting from tissue specific differentiated cells. The generation of self-
organizing tissue specific organoids that recapitulates the functions and the alteration of the 
tissue of origin would open new perspectives in the field of disease modeling and 
regenerative medicine.  
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Further work is required to evaluate if YAP reprogramming could occur also in vivo in order 
to facilitate tissue repair and regeneration. Direct application of the reprogramming procedure 
in vivo would provide an alternative to other reprogramming strategies employing either 
cocktail of transcription factors or the passage through a pluripotent state. In conclusion, the 
finding that YAP/TAZ can reprogram differentiated cells into their corresponding tissue 
specific stem cells may have great implications for understanding the mechanisms involved in 
the regulation of somatic stemness and also for the development of regenerative medicine 
applications.  
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EXPERIMENTAL PROCEDURES 
 
 
Reagents, plasmids and transfections 
Doxycycline hyclate, fibronectin, insulin, dexamethasone, dispase, hyaluronidase, NH4Cl,  
tamoxifen and 4-OH-tamoxifen were from Sigma. Murine EGF, murine bFGF, human 
Noggin and murine prolactin were from Peprotech. B27, Collagenase type I, DMEM/F12 and 
trypsin were from Life Technologies. R-Spondin1 was from Sino Biological. Matrigel was 
from BD Biosciences (Corning). Rat tail collagen type I was from Cultrex. DNaseI was from 
Roche. 
GFP- and Cre-expressing adenoviruses were from University of Iowa, Gene Transfer Vector 
Core. For inducible expression of YAP and TAZ, cDNA for siRNA-insensitive Flag-hYAP1 
wt, S94A (TEAD-binding mutant (Zhao et al., 2008) and 5SA (LATS-mutant sites (Aragona 
et al., 2013) and for Flag-mTAZ4SA (Azzolin et al., 2012) were subcloned in FUW-tetO-
MCS, obtained by substituting the Oct4 sequence in FUW-tetO-hOct4 (Addgene 
#20726(Hockemeyer et al., 2008) with a new multiple cloning site (MCS). This generated the 
FUW-tetO-wtYAP, FUW-tetO-YAPS94A, FUW-tetO-YAP5SA, FUW-tetO-TAZ4SA used 
throughout this study. FUW-tetO-EGFP plasmid was used as controls, as previously indicated 
(Cordenonsi et al., 2011). All our constructs are available in Addgene as #. 
For stable expression of GFP, we used pRRLSIN.cPPT.PGK-GFP.WPRE (gift of L. Naldini) 
lentiviral vector. 
All constructs were confirmed by sequencing.  
DNA transfections were done with TransitLT1 (Mirus Bio) according to manufacturer 
instructions. 
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Lentivirus preparation 
HEK293T cells (checked routinely for absence of mycoplasma contaminations) were kept in 
DMEM supplemented with 10% FBS (Life Technologies), Glutamine and Antibiotics (HEK 
medium). Lentiviral particles were prepared by transiently transfecting HEK293T with 
lentiviral vectors together with packaging vectors pMD2-VSVG and pPAX2 by using 
TransIT-LT1 (Mirus Bio) according to manufacturer instructions.  
 
Primary mammary epithelial cells (MECs) isolation and induction of yMaSCs 
Primary MECs were isolated from the mammary glands of 8- to 12-week-old virgin C57BL/6J 
mice (unless otherwise specified), according to standard procedures (Stingl et al., 2006). 
Mammary glands were minced and then digested with 6000 U/ml collagenase I and 2000 
U/ml hyaluronidase in the DMEM/F12 at 37°C for 1 hour with vigorous shaking. The 
digested samples were pipetted, spun down at 1500 rpm for 5 min, and incubated 3 min in 
0.64% buffered NH4Cl in order to eliminate contaminating red blood cells. After washing 
with DMEM/F12 + 5% FBS, cells were plated for 1 hour at 37°C in DMEM/F12+5% FBS: in 
this way, the majority of fibroblasts attached to the tissue culture plastic, whereas mammary 
epithelial populations did not; MEC were thus recovered in the supernatant and pelleted. 
After washing in PBS/EDTA 0.02%, MECs were further digested with 0.25% trypsin for 5 
min and 5 mg/ml dispase plus 100 mg/ml DNase I for other 10 min. The digested cells were 
diluted in DMEM/F12+5%FBS and filtered through 40 mm cell strainers to obtain single cell 
suspensions cells and washed once in the same medium. 
For separating various MEC subpopulations cells were stained for 30 min at 4°C with 
antibodies against CD49f (PE-Cy5, cat. 551129, BD Biosciences), CD29 (PE-Cy7, cat. 
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102222, BioLegend), CD61 (PE, cat. 553347, BD Biosciences), EpCAM (FITC, cat. 118208, 
BioLegend) and lineage markers (APC mouse Lineage Antibody Cocktail, cat. 51-9003632, 
BD Biosciences) in DMEM/F12. 
The stained cells were then resuspended in PBS/BSA 0,1% and sorted on a BD FACS Aria 
sorter (BD Biosciences) into luminal differentiated (LD) cells, luminal progenitor (LP) cells 
and mammary stem cells (MaSCs). 
Primary sorted subpopulations from FACS were plated on collagen I-coated supports and 
cultured in 2D in mammary (MG) medium (DMEM/F12 supplemented with glutamine, 
antibiotics, murine EGF, murine bFGF, and heparin with 2% FBS). 
For induction of yMaSCs, LD cells were transduced for 48 hours with FUW-tetO-YAP, or 
FUW-tetO-TAZ, in combination with rtTA-encoding lentiviruses. As a (negative) control, LD 
cells were transduced with either FUW-tetO-EGFP in combination with rtTA-encoding 
lentiviruses. After infection, adherent cells were washed and treated with doxycycline for 7 
days in MG medium for activating tetracycline-inducible gene expression (see scheme in 
Figure3A) to obtain “yMaSCs”. After doxycycline treatment for 7 days in 2D culture, 
yMaSCs were processed for further assays or analysis. Unless otherwise specificed, yMaSCs 
were generated from wild-type YAP (FUW-tetO-wtYAP, Addgene #). For the experiment 
depicted in Figures 4B and 6L we first FACS purified LD cells and MaSC-enriched 
populations (using CD61 and CD49f as previously described for Figure 2A) from K8-
CreERT2; R26-LSL-YFP/+ or K14-CreERT2; R26-LSL-YFP/+ virgin female mice.  These 
cells were plated and after attachment they were treated with  4OH-Tamoxifen for 24 hours. 
Cells were then transduced for 48 hours with FUW-tetO-wtYAP in combination with stable 
rtTA-encoding lentiviral supernatant. Negative control cells were provided by LD cells 
transduced with FUW-tetO-MCS (empty vector) in combination with rtTA-encoding 
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lentiviral supernatants. After infection, cells were washed, treated with doxycycline in MG 
medium as above. 
 
Matrigel culture of mammary colonies and organoids  
After infection in 2D cultures and induction with doxycycline for 7 days, mammary cells were 
detached with trypsin and seeded at a density of 1,000 cells/well in 24-well ultralow 
attachment plates (Corning) in mammary colony medium (DMEM/F12 containing glutamine, 
antibiotics, 5% Matrigel, 5% FBS, murine EGF, murine bFGF, and heparin) containing 
doxycycline (2 mg/ml). Primary colonies were counted 14 days after seeding. To show the 
self-renewal capacity of yMaSCs independently of exogenous YAP/TAZ supply (i.e, 
independently of doxycycline administration), primary colonies were recovered from the 
MG-colony medium by collecting the samples and incubation with an excess volume of ice 
cold HBSS in order to solubilize Matrigel. After 1 hour, colonies were rinsed 3 times in cold 
HBSS by centrifugation at 1000 rpm for 5 min and incubated in trypsin 0.05% for 30 min to 
obtain a single cell suspension. Cells were counted and re-seeded at 1,000 cells/well in 24-
well ultralow attachment plates in MG colony medium without doxycycline for further 
passaging.  
For mammary organoid formation, primary colonies were recovered from MG colony medium 
in cold HBSS and transferred in 100% Matrigel. After Matrigel formed a gel at 37°C, MG 
organoid medium was added (Advanced DMEM/F12 supplemented with Hepes, GlutaMax, 
antibiotics, B27, murine EGF, murine bFGF, heparin, Noggin and R-Spondin1). 2 weeks after 
seeding, organoids were removed from Matrigel, trypsin-dissociated and transferred to fresh 
Matrigel. Passages were performed in a 1:4-1:8 split ratio every 2 weeks. For analysis, 
colonies and organoids were recovered from Matrigel as before, and either embedded in OCT 
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medium (PolyFreeze, Sigma) to obtain frozen sections for immunofluorescence or processed 
for protein or RNA extraction. 
For the experiment depicted in Figure 3F, cells were plated into 96-well plate as single cells 
visually verified and their colony forming capacity was monitored. Based on the native 
fluorescence of EGFP-positive LD cells (negative control cells), we measured that the 
percentage of infection of our lentiviral-based reprogramming strategy is 50%.  
For a- and b-casein induction (Figures 7C-D), Matrigel-embeded organoids derived from 
yMaSCs or MaSCs were treated with MG organoid medium supplemented with insulin (10 
mg/ml) and dexamethasone (1 mg/ml) in the absence or presence of lactogenic hormone 
prolactin (5 mg/ml) for 7 days. Organoids were then recovered from Matrigel as before and 
processed for RNA extraction.  
 
Cleared Mammary Fat Pad Transplantation  
For induction of yMaSCs meant for in vivo injection, adherent luminal differentiated cells 
were transduced for 48 hours with FUW-tetO-wtYAP in combination with stable rtTA- and 
EGFP-encoding lentiviruses to trace with EGFP fluorescence the generation of transgenic 
mammary glands from yMaSCs. Negative control LD cells were transduced with FUW-tetO-
EGFP, rtTA and pRRL-CMV-GFP. After infection, cells were treated as before (washed, 
induced with doxycycline for 7 days in MG medium) and then injected in the cleared fat pads 
(see scheme in Figure 8A). Cell aliquots resuspended in 10 ml PBS/10% Matrigel were 
injected into the inguinal mammary fat pads of NOD-SCID mice (Charles River), which had 
been cleared of endogenous mammary epithelium at 3 weeks of age. Animals were then 
administered doxycycline in the drinking water for 2 weeks and then maintained without 
doxycycline for additional 8-10 weeks. Transplanted mammary fat pads were examined for 
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gland reconstitution by whole-mount staining, GFP native fluorescence and 
immunofluorescence on sections from paraffin-embedded biopsies. Only the presence of 
GFP-positive branched ductal trees with lobules and/or terminal end buds was scored as 
positive reconstitution. For whole-mount analysis of mammary glands, freshly-explanted 
glands were fixed in PFA 4% (2 hours) and ethanol 70% (overnight). Glands were 
rehydrated, stained overnight with hematoxylin, subsequently dehydrated in graded ethanols, 
cleared by incubation in benzyl-alcohol/benzyl benzoate (1:2; Sigma) and imaged. 
 
Immunofluorescence, stainings and microscopy 
For immunofluorescence on mammary colonies and organoids, outgrowths freshly recovered 
from Matrigel were embedded in OCT tissue-freezing medium (PolyFreeze, Sigma) and 
frozen on dry ice. 8 µm cryostat sections for all types of organoids were cut at –20 °C. 
Sections were mounted on glass slides and dried for at least 30 min. The sections were then 
fixed with 4% formaldehyde for 10 min. After washing with PBS the sections were 
permeabilized 10 min at RT with PBS 0.3% Triton X-100, and processed for 
immunofluorescence using the following conditions: blocking in 10% Goat Serum (GS) in 
PBS 0.1% Triton X-100 (PBST) for 1 hr followed by incubation with primary antibodies 
(diluted in 2% GS in PBST) overnight at 4°C, four washes in PBST and incubation with 
secondary antibodies (1:200 in 2% GS in PBST) for 2 hours at room temperature. Samples 
were counterstained with ProLong-DAPI (Molecular Probes, Life Technologies) to label cell 
nuclei. in PBST for 15 minutes, incubated 20 min with DAPI solution and mouted in 
glycerol. 
For immunofluorescence on mammary tissue, biopsies were fixed with PFA, paraffin-
embedded and cut in 10 µm-thick sections. Sections were re-hydrated and antigen retrieval 
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was performed by incubation in citrate buffer 0.01 M pH 6 at 95°C for 20 minutes. Slides 
were then permeabilized (10 min at RT with PBS 0.3% Triton X-100 for mammary sections 
and 10 min at RT with PBS 1% Triton X-100 for brain sections) and processed as described 
above.  
Primary antibodies: anti-a-SMA (A2547; 1:400) mouse monoclonal antibody. anti-E-cadherin 
(610181; 1:1000) was from BD Biosciences. anti-K14 (Ab7800; 1:100) mouse monoclonal 
antibody, anti-K8 (Ab14053; 1:100) chicken polyclonal antibody were from Abcam. anti-
GFP (A6455; 1:100) rabbit serum was from Life Technologies. anti-p63 (H137, sc-8343; 
1:50) polyclonal antibody and anti-Vimentin (Vim C-20, sc-7557-R; 1:100) rabbit polyclonal 
antibody was from Santa Cruz. K19 was detected using the monoclonal rat anti-Troma-III 
antibody (DSHB; 1:50). Alexa-conjugated secondary antibodies (Life Technologies): Alexa-
Fluor-488 donkey anti-mouse IgG (A21202), Alexa Fluor-488 donkey anti-rabbit IgG 
(A21206); Alexa Fluor-555 goat anti-chicken IgG (A21437). Goat anti-rat Cy3 (112-165-
167) was from Jackson Immunoresearch. 
Confocal images were obtained with a Leica TCS SP5 equipped with a CCD camera. Bright 
field and native-GFP (or tdTomato) images were obtained with a Leica DM IRB inverted 
microscope equipped with a CCD camera (Leica DFC 450C). Live cell imaging was 
performed with a A1Rsi+ laser scanning confocal microscope (Nikon) equipped with NIS-
Elements Advanced Research Software.  
 
 
Western blot 
Western blots were carried out as described in Ref. (Cordenonsi et al., 2011). Anti-YAP/TAZ 
(63.7; sc-101199) and anti-p63 (4A4; sc-8431) monoclonal antibodies were from Santa Cruz. 
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anti-GAPDH (MAB347) monoclonal antibody was from Millipore. Anti-K14 (Ab7800) 
mouse monoclonal antibody and anti-K8 (Ab14053) chicken polyclonal antibody were from 
Abcam. 
 
Quantitative Real-Time PCR (qRT-PCR)   
Cells or tissues were harvested in TriPure (Roche) for total RNA extraction, and contaminant 
DNA was removed by DNase treatment. qRT-PCR analyses were carried out on 
retrotranscribed cDNAs with Rotor-Gene Q (Qiagen) thermal cycler and analyzed with 
Rotor-Gene Analysis6.1 software. Expression levels are always given relative to Gapdh. 
 
Microarray experiments  
For microarray experiments, Mouse Genome 430 2.0 arrays (Affymetrix, Santa Clara, CA, 
USA) were used. Total RNA was extracted using TriPure (Roche) from luminal differentiated 
mammary cells (3 replicates), organoids derived from yMaSCs (3 replicates), and MaSCs (3 
replicates). 
RNA quality and purity were assessed on the Agilent Bioanalyzer 2100 (Agilent 
Technologies, Waldbronn, Germany); RNA concentration was determined using the 
NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies Inc.). RNA was then 
treated with DNaseI (Ambion). In vitro transcription, hybridization and biotin labeling were 
performed according to Affymetrix 3’IVT protocol (Affymetrix). As control of effective gene 
modulation and of the whole procedure, we monitored the expression levels of tissue-specific 
markers of differentiated cells or stem/progenitors by qRT-PCR prior to microarray 
hybridization and in the final microarray data. 
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All data analyses were performed in R (version 3.1.2) using Bioconductor libraries (BioC 3.0) 
and R statistical packages. Probe level signals were converted to log2 expression values using 
robust multi-array average procedure RMA (Irizarry et al., 2003) of Bioconductor affy 
package. Raw data are available at Gene Expression Omnibus under accession number 
GSE70174. 
Global unsupervised clustering was performed using the function hclust of R stats package 
with Pearson correlation as distance metric and average agglomeration method. Gene 
expression heatmaps have been generated using the function heatmap.2 of R gplots package 
after row-wise standardization of the expression values. Before unsupervised clustering, to 
reduce the effect of noise from non-varying genes, we removed those probe sets with a 
coefficient of variation smaller than the 90th percentile of the coefficients of variation in the 
entire dataset. The filter retained 4511 probe sets that are more variable across the samples . 
Differentially expressed genes were identified using Significance Analysis of Microarray 
algorithm coded in the samr R package as in Ref. (Tusher et al., 2001). To identify 
differentially expressed genes, we selected those probe sets with an FDR ≤ 1%.  
 
 
RNA Sequencing 
For RNA-seq, total RNAs was extracted with Trizol from small colonies emerging from YAP-
reprogrammed LD cells after 13 days in mammary colony medium and from freshly sorted 
LD and MaSC-enriched cell populations. RNA-seq libraries were prepared with TruSeq 
Stranded Total RNA with Ribo-Zero GOLD (Illumina), according to manufacturer’s 
instructions. Sequencing was performed on an Illumina HiSeq 2500 platform. Raw reads 
were aligned using TopHat	   (Kim et al., 2013) (version 2.0.5) to build version mm9 of the 
	   47	  
mouse genome. Counts for UCSC annotated genes were calculated from the aligned reads 
using HTSeq (Anders et al., 2015) (version 0.6.0). Normalization and differential analysis 
were carried out using edgeR package (Robinson et al., 2010) and R (version 3.0.0). Raw 
counts were normalized according to library size to obtain counts per millions (cpm). Only 
genes with a cpm greater than 1 in at least 1 sample were retained for differential analysis.  
Genes were considered differentially expressed with a Benjamini-Hochberg FDR less than or 
equal to 5%. Luminal genes in Figure 5D were those significantly upregulated in LD cells 
compared to MaSC-enriched cell populations; Basal genes were genes significantly 
upregulated in MaSC-enriched cell populations compared to LD cells. Luminal and Basal 
genes were further divided in three blocks each, corresponding to genes significantly 
upregulated (blocks C and F), significantly downregulated (blocks A and D), or displaying no 
significant changes (blocks B and E) in yMaSC colonies compared to MaSC-enriched cell 
populations (for blocks A, B and C) or LD cells (for blocks D, E or F). Genes specifically 
upregulated in yMaSC (block G) are defined as genes that were significantly upregulated in 
yMaSC colonies compared to both LD cells and MaSC-enriched cell populations and 
displaying no significant difference in expression between LD cells and MaSC-enriched cell 
populations. The lists of genes of blocks C and G were compared to gene expression 
signatures derived from (Wansbury et al., 2011), defining groups of genes that were found 
enriched in the epithelial cells of the fetal mammary bud. 
 
 
Mice  
C57BL/6J mice and NOD-SCID mice were purchased from Charles River. Transgenic lines 
used in the experiments were gently provided by: Cedric Blanpain (K8-CreERT2/R26-LSL-
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YFP) (Van Keymulen et al., 2011); Pierre Chambon (K14-CreERT2) (Li et al., 2002); Hans 
Clevers (Lgr5-GFP) (Barker et al., 2007). Tazfl/fl and double Yapfl/fl; Tazfl/fl conditional knock-
out mice were as described in Ref. (Azzolin et al., 2014). Animals were genotyped with 
standard procedures (Morsut et al., 2010) and with the recommended set of primers. Animal 
experiments were performed adhering to our institutional guidelines as approved by OPBA. 
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TABLES 
Table1. Sequences of qPCR oligos 
MOUSE 
GENE For Rev 
α-Casein CCCCTTTGGGCTTACTTTCC CATGAGGTGGATGGAGAATGG 
α-Sma TGCTGTCCCTCTATGCCTCT GAAGGAATAGCCACGCTCAG 
Aldh1L1 CAGGAGGTTTACTGCCAGCTA CACGTTGAGTTCTGCACCCA 
AnkrD1 CTGTGAGGCTGAACCGCTAT TCTCCTTGAGGCTGTCGAAT 
Areg TGGTGAACGGTGTGGAGAAA TGTGATAACGATGCCGATGC 
Axin2 GAGATGACGCCTGTGGAACC CCTGCTCAGACCCCTCCTTT 
Axl CGAGGCCAAACTCCCTATCC GGGCAGAGCCTTCAGTGTGT 
β-Casein CACTCCAGCATCCAGTCACA GGCATCTGTTTGTGCTTGGG 
Bdnf GGGTCACAGCGGCAGATAAA GCGAGTTCCAGTGCCTTTTG 
Bmp7 AAGGCCACGGAAGTCCATCT CCAAGGTCTCGGAAGCTGAC 
Claudin1 GGGGACAACA TCGTGACCG AGGAGTCGAAGACTTTGCACT 
Ctgf CTGCCTACCGACTGGAAGAC CATTGGTAACTCGGGTGGAG 
Dll1 TGAAGCCACGGTCAGGGATAC TGCAGACAGAACATACACCGACT 
Erbb3 TGCCAGATACGCACCTCAGA TACCCCTCCTCTTCCGGTTC 
Esr GGATGCTGAACCGCCCATGA CAGCCAGGCACACTCGAGAA 
Foxa1 ACAGCTACTACGCGGACACG GCTCGTGGTCATGGTGTTCA 
Fzd7 CGGCACCAAGACAGAGAAGC CAGGGCACAGCGTAGCTCTT 
Gapdh ATCCTGCACCACCAACTGCT GGGCCATCCACAGTCTTCTG 
Gpc3 AACCATGTCTGTGCCCAAGG GTTCTGCAAGGAAGCGCAGT 
Jag1 CCACCGAACACATTTGCAGCG CTGCAGAGATGGCCACGTGT 
Jag2 AGCCTGATCCAGAGCACAGC CGAGCCACAGCACACTGAAC 
Hey2 TGAGAAGACTAGTGCCAACAGC TGGGCATCAAAGTAGCCTTTA 
Igfbp4 GGGTATTCGGTCATCCGACA GGGCCATTCCTCAGACACAC 
K14 AGGACCTGAAGAGCAAGATC TCCTTGAGGCTCTCAATCTG 
K18 ATGACACCAACATCACAAGG ATCCACTTCCACAGTCAATC 
K19 AGGAGCTGAACACCCAGGTC GGGCTTCAAAACCGCTGAT 
K15 TCGCCACTTACCGGAACCT TTCCATCCACTGATTCCTCCA 
K6 ACCACCACCTCCTCCAGCAA ACACAGCCTCCTCAGTCCCA 
K5 TCTCTTCTGGCTACGGAGGA GAAGCTCATGCCTCCTTGAC 
K8 GGACATCGAGATCACCACCT TGAAGCCAGGGCTAGTGAGT 
Kit AGACTTGCTGGGACGCTGAC CGAGTTGACCCTCACGGAAT 
LGR4 TAACAGCCCCCAAGACCACA GCGACCAGGAAAATGAACCA 
LGR5 TCGTGATCGTCCCACTTCCT CAGGACCGTTTCTCAACATCG 
LGR6 GTGACCCTCATCTCCCGAAC AAGTGGCTCCCTCTGCCTTC 
Ltf GTCTGGCTGAGAAGGCAGGA GGTTTGGGGCTATGGCTAGG 
Mfge8 GAGGAGCAAGGAAGCAGCAA ATGCGGTTATGCCAGGACAC 
Myh11 GGTGAACGCCCTCAAGAGCA TCTGAGTCCCGAGCGTCCAT 
Nestin CCCTGAAGTCGAGGAGCTG CTGCTGCACCTCTAAGCGA 
ΔNp63 CCTGGAAAACAATGCCCAGAC GAGGAGCCGTTCTGAATCTGC 
Pgr TCCGGAACTTACACATTGATGACCA CCACATGGTAAGGCACAGCGA 
Prlr GGATCATTGTGGCCGTTCTC CGGAACTGGTGGAAAGATGC 
Procr GGAGAAAGGGCTGGACTGGT CCCCTCCCACACACACACTT 
Sfrp CTACTGGCCCGAGATGCTCA TTGTCGCATGGAGGACACAC 
Slug CTCACCTCGGGAGCATACAG GACTTACACGCCCCAAGGATG 
Timp3 GATGCCCCACGTGCAGTACA CCTTCATACACGCGCCCTGT 
Twist ACGCAGTCGCTGAACGAGGC GTCAGGGAAGTCGATGTACC 
Zeb2 ACACACAGGAAAGAGACCACACC GCGCTTGCCACATTTGTCACA 
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Figure 1. The Hippo signaling pathway in organ size control 
A, Schematic representation of  the mammalian Hippo pathway (Adapted from Piccolo et al., 
2014). 
B-C, Overexpression of Yorkie (YAP/TAZ orthologue) leads to organ overgrowth in 
Drosophila. (B) Expression of a Hippo-insensitive form of Yorkie in the eye primordium 
leads to an enlargement of the eye and head cuticle (right) compared to control (left) (adapted 
from Dong et al., 2007). (C) Yorkie overexpression in Drosophila wing imaginal discs results 
in an increase of the area of the discs (right) compared to control (left) (adapted from Huang 
et al., 2005). 
D, YAP overexpression in the liver of transgenic mice leads to organ overgrowth (right) 
compared to wild-type control (left) (adapted from Dong et al., 2007). 
E, Salvador knockout leads to cardiomegaly in neonatal mice (right) compared to control 
(left); ra, right atrium; la, left atrium; rv, right ventricle; lv, left ventricle (adapted from 
Heallen et al., 2011). 
	   60	  
	  
CD49f 
10
2  
10
3  
10
4  
10
5  
0 
C
D
61
 
102 103 104 105 
MaSC 
LP 
LD 
a 
102 103 104 105 
10
2  
10
3  
10
4  
10
5  
E
pC
A
M
 
SSC 
e d 
LD cells MaSCs LP cells 
b 
K14 
K8 
GAPDH 
LD
 c
el
ls
 
M
aS
C
s 
LP
 c
el
ls
 
c 
Extended Data Figure 1, 
Azzolin/Panciera/Fujimura et al. PICCOLO 
da
y 
14
 
da
y 
7 
da
y 
0 MaSCs LD cells 
f 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
1.2 
1.4 
Δ
N
p6
3 
Lg
r4
 
S
lu
g 
Ja
g2
 
G
pc
3 
B
m
p7
 
K
5 
α-
S
m
a 
M
yh
11
 
P
ro
cr
 
D
ll1
 
Ig
fb
b4
 
Lg
r5
 
Tw
is
t 
K
14
 
Ti
m
p3
 
K
15
 
Ze
b2
 
Ja
g1
 
A
xi
n2
 
S
frp
 
Fz
d7
 
B
dn
f 
Lg
r6
 
H
ey
2 
M
fg
e8
 
K
6 K
it 
K
8 
A
re
g 
C
la
ud
in
1 
E
sr
 
K
19
 
P
gr
 
K
18
 
Lt
f 
P
rlr
 
LD LP MaSCs 
m
R
N
A 
ex
pr
es
si
on
 Basal/Stem markers Luminal markers 
Ya
pf
l/f
l ;T
az
fl/
fl 
w
t 
Ad-GFP Ad-Cre 
C
ol
on
ie
s 
fro
m
 M
aS
C
s 
g 
1 plated cell in 1 single well; visually verified Experiment Mean ± SD 
#1 #2 #3  
!! !! !! !! !!
LD: rtTA/EGFP transduced 
# of single LD cells                                         n = 56 n = 64 n = 70   
% of single cells that gave rise to a single MaSCs-like colony 0.0% 0.0% 0.0% 0 
LD: rtTA/YAP S94A transduced 
# of single LD cells                                         n = 73 n = 46 n = 50   
% of single cells that gave rise to a single MaSCs-like colony 0.0% 0.0% 0.0% 0 
LD: rtTA/YAP wt transduced 
# of single LD cells                                         n = 71 n = 68 n = 57   
% of single cells that gave rise to a single MaSCs-like colony 19.7% 14.7% 21.1% 18.5 ± 3.4 
% of single MaSCs-like colonies that gave rise to an organoid 64.3% 70.0% 75.0% 69.8 ± 5.4 
SOSTITUIRE!MaSCs!con!Basal!cells!in!b!e!c?!
M
aS
C
 
LP
 c
el
ls
 
LD
 c
el
ls
 
K14 
K8 
GAPDH 
MaSC LP cells LD cells 
D
ay
 0
 
D
ay
 7
 
D
ay
 1
4 
MaSC LD cells 
A B 
C D E 
FIGURE 2 
LD
 c
el
ls
 
M
aS
C
s 
LP
 c
el
ls
 
YAP 
TAZ 50 kDa 
60 kDa 
40 kDa 
p63 60 kDa 
GAPDH 0 
0,5 
1 
Ctgf Axl 
m
R
N
A 
ex
pr
es
si
on
 
MaSCs 
LP cells 
LD cells 
Ad-GFP 
Ad-Cre 
O
rg
an
oi
ds
 fr
om
 Y
ap
fl/
fl ; 
Ta
zf
l/f
l  
M
aS
C
s 
F G H 
	   61	  
Figure 2. Characterization of the FACS-purified mammary gland cells 
A, FACS profile showing the distribution of Lin–/EpCAM+ mammary cells according to their 
CD49f/CD61 antigenic profile. Three subpopulations were separated: a MaSC-enriched 
fraction (EpCAMlowCD49fhighCD61+), luminal progenitors (LP, EpCAMhighCD49flowCD61+), 
and luminal differentiated cells (LD, EpCAMhighCD49flowCD61-).  
B, Comparison by qRT-PCR for the indicated basal/stem and luminal markers of FACS-
purified MaSCs, LP, and LD. Data are normalized to Gapdh expression and are referred to 
MaSC levels for basal genes, to LP levels for Hey2, and to LD levels for all the other luminal 
markers (each set to 1). Results are representative of at least three independent experiments 
(each using mammary glands from n=20 mice) performed in triplicate. 
C, Western blot analysis for the indicated basal and luminal markers in FACS-purified 
MaSCs, LP and LD cells. GAPDH serves as loading control. 
D, Representative images at the indicated time points of mammary colonies formed by the 
indicated cells in mammary colony medium. Pictures are representative of three independent 
experiments performed with six technical replicates. Scale bar, 170 µm.  
E, Representative images of whole mount hematoxylin staining of cleared fat pads injected 
with purified MaSCs (leading to outgrowth of a ductal mammary tree) or of LD cells as 
negative control. Scale bars, 1 cm.   
F, Western blots for YAP, TAZ and p63 in the FACS- purified populations; GAPDH serves as 
loading control. 
G, qRT-PCRs for Ctgf and Axl in the indicated cell populations (mean + s.d.). Results are 
representative of three independent experiments (each using mammary glands from n=20 
mice), performed in triplicate.  
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H, Representative images of organoids obtained from Yapfl/fl; Tazfl/fl MaSCs. Organoids were 
transduced with Ad-Cre or Ad-GFP (as control) during passaging. Panels are representative 
images of the resulting outgrowths. No organoid ever formed in absence of YAP/TAZ. Scale 
bar, 250 µm. 
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Figure 3. Conversion of Luminal Differentiated cells in yMaSCS by YAP/TAZ 
expression 
A, Schematic representation of the experiments performed with LD cells. Doxy stands for 
doxycycline. 
B-C, Representative images (B) and quantifications (C) of mammary colonies formed by the 
indicated cells, 15 days after seeding in mammary colony medium. Data in (C) are presented 
as mean + s.d. and are representative of five independent experiments, each with six technical 
replicates. 
D-E, Quantifications of secondary (D) and tertiary (E) colonies formed by primary mammary 
colonies after dissociation and re-seeding in mammary colony medium without doxycycline. 
Data are representative of three independent experiments performed with six technical 
replicates, and presented as mean + s.d. 
F, Quantification of the conversion rates of single LD cells plated in 96-well expressing the 
indicated constructs plates into a MaSC-like state as determined by % of colony formation. 
EGFP- and YAP S94A-transduced cells serve as negative control. 
G, Quantifications of mammary colonies formed by MaSCs transduced with EGFP or YAP wt 
encoding vectors, 15 days after seeding in mammary colony medium. Data are presented as 
mean + s.d. 
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Figure 4. Genetic lineage tracing of yMaSCs 
A, Representation of the genetic lineage tracing strategies used to trace mammary cell 
lineages. 
B, Immunofluorescence analysis with anti-YFP of traced cells derived from K8-CreER/R26-
YFP or K14-CreER/R26-YFP during colony formation. Days indicate the time in colony 
medium. Scale bars, 62 µm. 
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Figure 1,  
Azzolin/Panciera/Fujimura et al. PICCOLO 
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Figure 5. Characterization of the early stage of YAP induced reprogramming 
A-C, Immunostainings for K14/K8 (A, at different stages of the outgrowths) and α-SMA (B) 
in colonies originating from yMaSCs. Scale bars, 36 µm. C, quantifications of individual 
cells, positive for the indicated markers, inside the colonies.  
D, Heatmap of genes differentially expressed between LD cells, yMaSCs colonies (two 
independent preparations) and MaSC-enriched cell population (MaSCs). 
E, Comparison by qRT-PCR of FACS-purified MaSC-enriched basal cells (MaSCs) from the 
mammary gland and yMaSC colonies. Purified LD cells were used as control. Data are 
normalized to Gapdh expression and are referred to LD levels for all the luminal genes, to 
MaSCs levels for myoepithelial and basal genes, and to yMaSC colonies levels for yMaSC-
specific genes (each set to 1). 
F, Schematic representation of the experiments performed with LD cells. Doxy stands for 
doxycycline. 
G, Representative images of Lgr5-GFP-positive cells emerging from LDs infected with 
lentiviruses for rtTA in combination with empty vector or inducible YAP (wt or S94A) after 7 
days of treatment with doxycycline. Lgr5-GFP-expressing MaSCs colonies are presented as 
controls. Scale bar, 31 mm.  
I, Quantification of Lgr5-GFP-positive cells emerging from indicated LD transfectants, at 
different time points during doxycycline treatment. Results are presented as mean + s.d of 10 
different fields (each containing 26-50 transfectants), and were repeated twice.  
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Figure 2,  
Azzolin/Panciera/Fujimura et al. PICCOLO 
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Figure 6. Morphological characterization of yMaSC derived organoids 
A, Representative images of yMaSCs outgrowths at the indicated time points. Cultures were 
in mammary colony medium until day 14 and then transferred to organoid medium in absence 
of doxycycline. Scale bar 250 mm. 
B, Representative images of MaSCs or yMaSCs organoids (derived from reprogramming of 
LDs with the indicated vectors). Scale bar 250 mm. 
C, Immunostaining for E-Cadherin on frozen sections of MaSCs and yMaSCs derived 
organoiods. 
D-I,  Confocal immunofluorescence analysis for basal (K14, α-SMA, p63) and luminal 
markers (K8, K19) on frozen sections of MaSCs and y MaSCs derived organoids. Scale bar, 
17 mm. 
L, immunostaining with anti-YFP combined with either anti-K14 or anti-K8 antibodies of 
yMaSCs-derived organoids obtained from K8CreER/R26-YFP-traced LD cells. Scale bar 49 
µm. 
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Figure 7. Molecular and functional characterization of yMaSC derived organoids 
A, FACS-purified MaSC-enriched basal cells (MaSCs) from the mammary gland and FACS-
purified yMaSCs from yMaSC-derived organoids were analized for the expression of basal 
and luminal marker by qRT-PCR. LD cells serves as control. Data are normalized to Gapdh 
expression and are referred to MaSCs levels for basal genes and to LD levels for all the 
luminal markers (each set to 1). 
B, Unsupervised hierarchical clustering of gene expression profiles in LD cells, organoids 
from MaSCs (M) and organoids from yMaSCs (yM). Each column represents one separated 
biological sample. Genes are ordered according to the decreasing average expression level 
in LD. Representative genes upregulated in the samples are shown on the left. Red: 
representative genes upregulated in LDs. Green: representative genes upregulated in MaSC 
and yMaSC derived organoids. 
C-D, Treatment with hormon prolactin triggers the expression of  β-casein (C) and α-casein 
(D) in MaSCs and yMaSCs (from YAP wt) derived organoids. qRT-PCR data were 
normalized to Gapdh expression and presented as mean + s.d.; results are representative of 
two independent experiments performed in triplicate.  
E, Representative images of organoids obtained from Yapfl/fl; Tazfl/fl yMaSCs. Organoids were 
transduced with Ad-Cre or Ad-GFP (as control) during passaging. Panels are representative 
images of the resulting outgrowths. No organoid ever formed in absence of YAP/TAZ. Scale 
bar, 250 µm. 
F, Western blots analysis for YAP and TAZ in the indicated cells. Lane 1: FACS-purified LD 
cells. Lane 2: yMaSCs (wtYAP) after seven days of doxycycline treatment; tagged Flag-
hYAP is induced. Lane 3: organoids from yMaSCs cultured in the absence of doxycycline 
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(Flag-hYAP turned off, but endogenous YAP/TAZ remain expressed). Lane 4: endogenous 
MaSCs. GAPDH serves as loading control. 
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Figure 8. Reconstitution capacity of yMaSC 
A, Schematic representation of the injection experiments performed. Constitutive GFP 
expressing vector (PRRL-GFP) was used to trace the cells.  Doxy stands for doxycycline. 
B, Mammary gland reconstitution generated by stably GFP-expressing yMaSCs (from YAP 
wt) in virgin females. Left panel: native GFP fluorescence (scale bar 0,5 cm); Central panel: 
whole mount hematoxylin staining (scale bar 0,5 cm); Right panel: Hematoxylin staining on 
histological section (scale bar 21 µm).  
C, Hematoxylin staining of cleared fat pad with reconstituted mammary trees from 
transplanted yMaSCs (from wtYAP), native MaSCs (positive control) and rtTA/EGFP control 
LD cells (negative control). Scale bar, 0.5 cm.  
D-F Immunostaining for GFP (D), and the indicated basal (K14, a-SMA) and luminal (K8, 
K19) markers (E-F) on reconstituted mammary gland sections. Scale bar 21 µm. 
G, Mammary gland reconstitution generated by yMaSC in an impregnated female. Left panel: 
native GFP fluorescence (scale bar 0,5 cm); Central panel: whole mount hematoxylin staining 
(scale bar 0,5 cm); Right panel: Hematoxylin staining on histological section (scale bar 21 
µm). Note that upon gestation and lactation, the mammary gland is constituted by alveoli 
filled with milk.	  	  
